Total Payments
$6,158
2024 Payments
$2,008
Companies
28
Transactions
377
Medicare Patients
1,213
Medicare Billing
$107,808
Payment Breakdown by Category
Food & Beverage$6,145 (99.8%)
Education$12.73 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,145 | 376 | 99.8% |
| Education | $12.73 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,859 | 106 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $838.23 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $707.60 | 52 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $639.26 | 35 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $309.88 | 24 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $304.98 | 28 | $0 (2023) |
| PFIZER INC. | $213.96 | 12 | $0 (2024) |
| GENZYME CORPORATION | $193.41 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $189.56 | 10 | $0 (2024) |
| Ardelyx, Inc. | $121.84 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,008 | 105 | ABBVIE INC. ($596.02) |
| 2023 | $1,588 | 93 | ABBVIE INC. ($483.50) |
| 2022 | $1,618 | 108 | ABBVIE INC. ($434.71) |
| 2021 | $943.71 | 71 | AbbVie Inc. ($345.23) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 309 | 389 | $78,444 | $25,080 |
| 2022 | 5 | 328 | 453 | $86,452 | $30,718 |
| 2021 | 5 | 327 | 434 | $81,296 | $31,156 |
| 2020 | 5 | 249 | 364 | $63,329 | $20,854 |
Total Patients
1,213
Total Services
1,640
Medicare Billing
$107,808
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 176 | $38,015 | $12,365 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 68 | $11,104 | $3,559 | 32.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 67 | $9,581 | $3,361 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 23 | $8,740 | $2,530 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 26 | $7,278 | $2,223 | 30.5% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 13 | 13 | $2,304 | $846.17 | 36.7% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 16 | 16 | $1,422 | $196.20 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 235 | $44,180 | $16,215 | 36.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 111 | $15,691 | $4,977 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 44 | $11,220 | $4,582 | 40.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $10,260 | $3,393 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 20 | $3,760 | $1,262 | 33.6% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 16 | 16 | $1,341 | $289.46 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 211 | 288 | $54,144 | $20,992 | 38.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 34 | $8,670 | $3,942 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 70 | $9,100 | $3,238 | 35.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 20 | $7,600 | $2,577 | 33.9% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 22 | 22 | $1,782 | $407.40 | 22.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 169 | 258 | $48,481 | $16,174 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $7,220 | $2,360 | 32.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 22 | 43 | $3,182 | $1,019 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 18 | $2,340 | $744.78 | 31.8% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2020 | 26 | 26 | $2,106 | $555.60 | 26.4% |
About Melissa Larson, FNP
Melissa Larson, FNP is a Nurse Practitioner healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1336625409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Larson, FNP has received a total of $6,158 in payments from pharmaceutical and medical device companies, with $2,008 received in 2024. These payments were reported across 377 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,145).
As a Medicare-enrolled provider, Larson has provided services to 1,213 Medicare beneficiaries, totaling 1,640 services with total Medicare billing of $107,808. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Goshen, IN
- Active Since 07/12/2018
- Last Updated 05/03/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1336625409
Products in Payments
- DUPIXENT (Biological) $832.67
- ENTYVIO (Biological) $667.38
- RINVOQ (Biological) $541.91
- STELARA (Biological) $524.06
- SKYRIZI (Biological) $397.06
- HUMIRA (Biological) $367.84
- ZENPEP (Drug) $304.98
- XELJANZ (Drug) $213.96
- LINZESS (Drug) $205.38
- MAVYRET (Drug) $164.69
- TRULANCE (Drug) $149.63
- XIFAXAN (Drug) $146.58
- CREON (Drug) $136.83
- REMICADE (Biological) $136.45
- IBSRELA (Drug) $121.84
- OCALIVA (Drug) $97.12
- APOLLO ESG System (Device) $84.58
- OMVOH (Drug) $80.31
- Linzess (Drug) $76.45
- GATTEX (Drug) $68.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Goshen
Leah Miller, N.p, N.P
Nurse Practitioner — Payments: $3,600
Nurse Practitioner $3,600
Brittany Hembree, Np, NP
Nurse Practitioner — Payments: $3,335
Nurse Practitioner $3,335
Stephanie Cross, Np, NP
Nurse Practitioner — Payments: $2,363
Nurse Practitioner $2,363
Katherine O'toole, Np-C, NP-C
Nurse Practitioner — Payments: $2,302
Nurse Practitioner $2,302
Mrs. Anne Love, Np, NP
Nurse Practitioner — Payments: $1,553
Nurse Practitioner $1,553
Grace Darnell, Msn, Np-C, Rn, MSN, NP-C, RN
Nurse Practitioner — Payments: $1,372
Nurse Practitioner $1,372